Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 29506
Licensor grants Licensee perpetual, non-exclusive rights to certain intellectual property, including all clinical and biomarker data related to ficlatuzumab, to develop and commercialize VeriStrat and Licensee granted Licensor perpetual, non-exclusive rights to certain intellectual property, including diagnostic data related to VeriStrat, with respect to the development and commercialization of ficlatuzumab; each license includes the right to sublicense.
IPSCIO Record ID: 278110
Licensor granted the perpetual, non-exclusive rights to certain intellectual property, including diagnostic data related to VeriStrat, with respect to the development and commercialization of ficlatuzumab.
VeriStratÂ® is Licensorâ€™s proprietary companion diagnostic test. VeriStrat test is a predictive and prognostic blood-based proteomic test for patients with advanced non-small cell lung cancer.
A retrospective exploratory analysis uses VeriStratÂ®, a commercially available serum protein test, to identify patients most likely to benefit from the addition of ficlatuzumab, AVEOâ€™s HGF inhibitory antibody, to epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitor (TKI) therapy in a randomized Phase 2 study of ficlatuzumab and gefitinib (IRESSAÂ®) in previously untreated Asian subjects with non-small cell lung cancer (NSCLC).
IPSCIO Record ID: 5622
Licensee and its Affiliates shall have the right to use the Trademarks, solely in connection with the use of the Colon 101 ELISA Test.
CDX field means clinical diagnostic testing services performed by a reference laboratory using a test on human samples, the results of which are provided to hospitals, physicians, payers, and/or patients for use in the clinical management of patients.
RDX Field means use in vitro diagnostic testing services in Clinical Trials.
The Licensee shall have the right to use the Trademarks.
'RDX Field' means use in in vitro diagnostic testing services in Clinical Trials.